Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression
Background & Aims: Primary sclerosing cholangitis (PSC) is a chronic heterogenous cholangiopathy with unknown etiology where chronic inflammation of the bile ducts leads to multifocal biliary strictures and biliary fibrosis with consecutive cirrhosis development. We here aimed to identify a...
Saved in:
| Main Authors: | , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-03-01
|
| Series: | JHEP Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2589555924002714 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1825199412662501376 |
|---|---|
| author | Alena Laschtowitz Eric L. Lindberg Anna-Maria Liebhoff Laura Anne Liebig Christian Casar Silja Steinmann Adrien Guillot Jun Xu Dorothee Schwinge Michael Trauner Ansgar Wilhelm Lohse Stefan Bonn Norbert Hübner Christoph Schramm |
| author_facet | Alena Laschtowitz Eric L. Lindberg Anna-Maria Liebhoff Laura Anne Liebig Christian Casar Silja Steinmann Adrien Guillot Jun Xu Dorothee Schwinge Michael Trauner Ansgar Wilhelm Lohse Stefan Bonn Norbert Hübner Christoph Schramm |
| author_sort | Alena Laschtowitz |
| collection | DOAJ |
| description | Background & Aims: Primary sclerosing cholangitis (PSC) is a chronic heterogenous cholangiopathy with unknown etiology where chronic inflammation of the bile ducts leads to multifocal biliary strictures and biliary fibrosis with consecutive cirrhosis development. We here aimed to identify a PSC-specific gene signature associated with biliary fibrosis development. Methods: We performed RNA-sequencing of 47 liver biopsies from people with PSC (n = 16), primary biliary cholangitis (PBC, n = 15), and metabolic dysfunction-associated steatotic liver disease (MASLD, n = 16) with different fibrosis stages to identify a PSC-specific gene signature associated with biliary fibrosis progression. For validation, we compared an external transcriptome data set of liver biopsies from people with PSC (n = 73) with different fibrosis stages (baseline samples from NCT01672853). Results: Differential gene expression analysis of the liver transcriptome from patients with PSC with advanced vs. early fibrosis revealed 431 genes associated with fibrosis development. Of those, 367 were identified as PSC-associated when compared with PBC or MASLD. Validation against an external data set of 73 liver biopsies from patients with PSC with different fibrosis stages led to a condensed set of 150 (out of 367) differentially expressed genes. Cell type specificity assignment of those genes by using published single-cell RNA-Seq data revealed genetic disease drivers expressed by cholangiocytes (e.g. CXCL1, SPP1), fibroblasts, innate, and adaptive immune cells while deconvolution along fibrosis progression of the PSC, PBC, and MASLD samples highlighted an early involvement of macrophage- and neutrophil-associated genes in PSC fibrosis. Conclusions: We reveal a PSC-attributed gene signature associated with biliary fibrosis development that may enable the identification of potential new biomarkers and therapeutic targets in PSC-related fibrogenesis. Impact and implications:: Primary sclerosing cholangitis (PSC) is an inflammatory liver disease that is characterized by multifocal inflammation of bile ducts and subsequent biliary fibrosis. Herein, we identify a PSC-specific gene set of biliary fibrosis progression attributing to a uniquely complex milieu of different cell types, including innate and adaptive immune cells while neutrophils and macrophages showed an earlier involvement in fibrosis initiation in PSC in contrast to PBC and metabolic dysfunction-associated steatotic liver disease. Thus, our unbiased approach lays an important groundwork for further mechanistic studies for research into PSC-specific fibrosis. |
| format | Article |
| id | doaj-art-5329db3b2be549bb9a330da998f271ee |
| institution | Kabale University |
| issn | 2589-5559 |
| language | English |
| publishDate | 2025-03-01 |
| publisher | Elsevier |
| record_format | Article |
| series | JHEP Reports |
| spelling | doaj-art-5329db3b2be549bb9a330da998f271ee2025-02-08T05:00:54ZengElsevierJHEP Reports2589-55592025-03-0173101267Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progressionAlena Laschtowitz0Eric L. Lindberg1Anna-Maria Liebhoff2Laura Anne Liebig3Christian Casar4Silja Steinmann5Adrien Guillot6Jun Xu7Dorothee Schwinge8Michael Trauner9Ansgar Wilhelm Lohse10Stefan Bonn11Norbert Hübner12Christoph Schramm13Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Department of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, Germany; Cardiovascular and Metabolic Sciences, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Berlin Institute of Health (BIH), Berlin, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, Germany; Corresponding authors. Address: I.Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany; Tel.: +49 40 7410 52545 (C. Schramm); Tel.: +49 30 450 630127 (A. Laschtowitz).Cardiovascular and Metabolic Sciences, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; Department of Medicine I, LMU University Hospital, LMU Munich, Munich, Germany; Gene Center, Department of Biochemistry, Ludwig Maximilians Universität, Munich, GermanyInstitute of Medical Systems Biology, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Cardiovascular and Metabolic Sciences, Max-Delbrueck-Center for Molecular Medicine, Berlin, GermanyDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, Germany; Bioinformatics Core, University Medical Center Hamburg-Eppendorf; Hamburg, GermanyDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, GermanyDepartment of Hepatology and Gastroenterology, Charité - Universitätsmedizin Berlin, Berlin, GermanyDepartment of Biomarker Sciences, Gilead Sciences Inc., San Mateo, California, United States of AmericaDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, GermanyEuropean Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, Germany; Division of Gastroenterology and Hepatology, Department of Medicine III, Medical University of Vienna, Vienna, AustriaDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, GermanyInstitute of Medical Systems Biology, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, GermanyCardiovascular and Metabolic Sciences, Max-Delbrueck-Center for Molecular Medicine, Berlin, Germany; German Center for Cardiovascular Research (DZHK), partner site Berlin, Berlin, Germany; Charité - Universitätsmedizin Berlin, Berlin, GermanyDepartment of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; European Reference Network for Hepatological Diseases (ERN-RARE LIVER), Hamburg, Germany; Martin-Zeitz-Center for Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Hamburg Center for Translational Immunology (HCTI), Hamburg, Germany; Corresponding authors. Address: I.Medizinische Klinik, Universitätsklinikum Hamburg-Eppendorf, Martinistraße 52, 20251 Hamburg, Germany; Tel.: +49 40 7410 52545 (C. Schramm); Tel.: +49 30 450 630127 (A. Laschtowitz).Background & Aims: Primary sclerosing cholangitis (PSC) is a chronic heterogenous cholangiopathy with unknown etiology where chronic inflammation of the bile ducts leads to multifocal biliary strictures and biliary fibrosis with consecutive cirrhosis development. We here aimed to identify a PSC-specific gene signature associated with biliary fibrosis development. Methods: We performed RNA-sequencing of 47 liver biopsies from people with PSC (n = 16), primary biliary cholangitis (PBC, n = 15), and metabolic dysfunction-associated steatotic liver disease (MASLD, n = 16) with different fibrosis stages to identify a PSC-specific gene signature associated with biliary fibrosis progression. For validation, we compared an external transcriptome data set of liver biopsies from people with PSC (n = 73) with different fibrosis stages (baseline samples from NCT01672853). Results: Differential gene expression analysis of the liver transcriptome from patients with PSC with advanced vs. early fibrosis revealed 431 genes associated with fibrosis development. Of those, 367 were identified as PSC-associated when compared with PBC or MASLD. Validation against an external data set of 73 liver biopsies from patients with PSC with different fibrosis stages led to a condensed set of 150 (out of 367) differentially expressed genes. Cell type specificity assignment of those genes by using published single-cell RNA-Seq data revealed genetic disease drivers expressed by cholangiocytes (e.g. CXCL1, SPP1), fibroblasts, innate, and adaptive immune cells while deconvolution along fibrosis progression of the PSC, PBC, and MASLD samples highlighted an early involvement of macrophage- and neutrophil-associated genes in PSC fibrosis. Conclusions: We reveal a PSC-attributed gene signature associated with biliary fibrosis development that may enable the identification of potential new biomarkers and therapeutic targets in PSC-related fibrogenesis. Impact and implications:: Primary sclerosing cholangitis (PSC) is an inflammatory liver disease that is characterized by multifocal inflammation of bile ducts and subsequent biliary fibrosis. Herein, we identify a PSC-specific gene set of biliary fibrosis progression attributing to a uniquely complex milieu of different cell types, including innate and adaptive immune cells while neutrophils and macrophages showed an earlier involvement in fibrosis initiation in PSC in contrast to PBC and metabolic dysfunction-associated steatotic liver disease. Thus, our unbiased approach lays an important groundwork for further mechanistic studies for research into PSC-specific fibrosis.http://www.sciencedirect.com/science/article/pii/S2589555924002714Primary sclerosing cholangitisBiliary fibrosisBulk RNA-sequencingLiver transcriptome |
| spellingShingle | Alena Laschtowitz Eric L. Lindberg Anna-Maria Liebhoff Laura Anne Liebig Christian Casar Silja Steinmann Adrien Guillot Jun Xu Dorothee Schwinge Michael Trauner Ansgar Wilhelm Lohse Stefan Bonn Norbert Hübner Christoph Schramm Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression JHEP Reports Primary sclerosing cholangitis Biliary fibrosis Bulk RNA-sequencing Liver transcriptome |
| title | Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression |
| title_full | Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression |
| title_fullStr | Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression |
| title_full_unstemmed | Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression |
| title_short | Liver transcriptome analysis reveals PSC-attributed gene set associated with fibrosis progression |
| title_sort | liver transcriptome analysis reveals psc attributed gene set associated with fibrosis progression |
| topic | Primary sclerosing cholangitis Biliary fibrosis Bulk RNA-sequencing Liver transcriptome |
| url | http://www.sciencedirect.com/science/article/pii/S2589555924002714 |
| work_keys_str_mv | AT alenalaschtowitz livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT ericllindberg livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT annamarialiebhoff livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT lauraanneliebig livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT christiancasar livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT siljasteinmann livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT adrienguillot livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT junxu livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT dorotheeschwinge livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT michaeltrauner livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT ansgarwilhelmlohse livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT stefanbonn livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT norberthubner livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression AT christophschramm livertranscriptomeanalysisrevealspscattributedgenesetassociatedwithfibrosisprogression |